|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.85 USD | +2.20% |
|
+7.31% | -6.66% |
| 07-01 | Sector Update: Health Care Stocks Rise in Late Afternoon Trading | MT |
| 07-01 | Sector Update: Health Care Stocks Advance Tuesday Afternoon | MT |
EPS & Dividend: Supernus Pharmaceuticals, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.36 | 0.98 | 1.04 | 0.02 | 1.32 | 0.115 | -0.485 | 0.295 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 25.16 | 29.16 | 35.67 | 28.94 | 36.16 | 33.12 | 33.12 | 33.12 |
| Nbr of stocks (in thousands) | 52,685 | 53,181 | 54,058 | 54,633 | 55,219 | 62,619 | - | - |
| Announcement Date | 2/25/21 | 4/13/22 | 2/28/23 | 2/27/24 | 2/25/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Supernus Pharmaceuticals, Inc.
| 2025-07-30 | Q2 2025 Earnings Release (Projected) |
| 2026-03-02 | Q4 2025 Earnings Release (Projected) |
| 2026-05-11 | Q1 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
| - | - | 288x | - | - | ||
| 2.07% | 2.15% | 15.83x | 1.53x | 2.55x | ||
| 2.43% | 2.51% | 23.25x | 1.48x | 2.23x | ||
| - | - | 11.93x | 8.77x | 5.92x | ||
| 0.44% | 0.44% | 72.14x | 3.98x | 3.66x | ||
| -.--% | 0.05% | 57.4x | 11.4x | 10.46x | ||
| 0.62% | 0.8% | 34.15x | 3.93x | 7.03x | ||
| 2.03% | 2.29% | 12.24x | 1.11x | - | ||
| -.--% | -.--% | 13.46x | -59.29x | 1.82x | ||
| - | - | - | - | - | ||
| Average | 1.08% | 1.18% | 58.71x | -3.39x | 4.81x | |
| Weighted average by Cap. | 1.75% | 1.83% | 28.84x | 1.65x | 3.50x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition